Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.62 -2.21 (-2.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011)

Updated

Ani Pharmaceuticals (ANIP) reported Notes Payables of $1.23 million for Q3 2011, up 3.9% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011) Analysis & Trends

At the end of FY2010, Ani Pharmaceuticals posted Notes Payables of $1.11 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Ani Pharmaceuticals 1.78 Bn 565.34 Mn 165.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 1.23 Mn
Jun 30, 2011 1.19 Mn
Dec 31, 2010 1.11 Mn
API Access

Ani Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ANIP&period=max&api_key=YOUR_API_KEY